TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 3 | -2 | -6 | -3 | 10 | 24 | 48 | 12 |
| P | %wins | 33 | 0 | 67 | 67 | 67 | 33 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/21 19:43 | 8/17/21 | KRTX | Karuna Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Paul Steven M | MA | DO | P,amp; C | P.m | 250 | 105.87 | 0 | 2 | 2 | 109 | I | |||||||||||||||
7/1/19 20:26 | 6/28/19 | KRTX | Karuna Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Paul Steven M | MA | DO | P,CEO | P.d | 230 | 23.04 | 0 | 10 | New | 10 | D | |||||||||||||||
1/15/16 17:01 | 1/14/16 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Paul Steven M | MA | DO | P,CEO | P | 141 | 14.07 | 2 | 10 | 1 | 872 | D | -50 | -32 | -32 | -15 | -8 | -10 | -28 | -12 | -8 | -14 | ||||
1/28/15 17:10 | 1/26/15 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Paul Steven M | MA | D | P | 95 | 95.00 | 33 | 1 | New | 1 | D | 286 | 18 | 79 | 2 | -5 | 2 | -3 | 3 | 3 | -2 | 14 | 14 | 41 | -22 | ||
7/23/14 19:01 | 7/23/14 | SAGE | Sage Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Paul Steven M | MA | D | P | 180 | 18.00 | 33 | 10 | 1 | 804 | D | -1 | -6 | 6 | 27 | 40 | 179 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |